Top

BMC Psychiatry

Published in:

01-12-2021 | Mood Disorders | Research

Depression, post-traumatic stress, anxiety, and fear of COVID-19 in the general population and health-care workers: prevalence, relationship, and explicative model in Peru

Authors: David Villarreal-Zegarra, Anthony Copez-Lonzoy, Ana L. Vilela-Estrada, Jeff Huarcaya-Victoria

Published in: BMC Psychiatry | Issue 1/2021

Abstract

Background

This study has two aims. First, determine the fit of the fear model to COVID-19, anxiety, and post-traumatic stress in the general population and health-care workers. Second, determine which model best explains the relationship between depression and the triad of fear, anxiety, and post-traumatic stress in both groups.

Method

A cross-sectional study was conducted using self-reported questionnaires for anxiety, fear of COVID-19, depression, and post-traumatic stress. Information was collected from adults living in Lima, the capital and the most populous city in Peru. The explanatory models were evaluated using a structural equation model.

Results

A total of 830 participants were included, including general population (n = 640) and health-care workers (n = 190). A high overall prevalence of depressive symptoms (16%), anxiety (11.7%), and post-traumatic stress (14.9%) were identified. A higher prevalence of depressive, anxious, or stress symptoms was identified in the general population (28.6%) compared to health-care workers (17.9%). The triad model of fear of COVID-19, anxiety, and stress presented adequate goodness-of-fit indices for both groups. A model was identified that manages to explain depressive symptoms in more than 70% of the general population and health-care workers, based on the variables of the triad (CFI = 0.94; TLI = 0.94; RMSEA = 0.06; SRMR = 0.06). In the general population post-traumatic stress mediated the relationship between anxiety and depression (β = 0.12; 95%CI = 0.06 to 0.18) which was significant, but the indirect effect of post-traumatic stress was not significant in health care workers (β = 0.03; 95%CI = − 0.11 to 0.19).

Limitations

The prevalence estimates relied on self-reported information. Other variables of interest, such as intolerance to uncertainty or income level, could not be evaluated.

Conclusions

Our study proposes and tests one model that explains more than 70% of depressive symptoms. This explanatory model can be used in health contexts and populations to determine how emotional factors can affect depressive symptoms.

Sala Situacional COVID-19 Perú [https://covid19.minsa.gob.pe/sala_situacional.asp]. Accessed 6 June 2021.

Huremovic D. Social distancing, quarantine, and isolation. In: Huremovic D, editor. Psychiatry of pandemics a mental health response to infection outbreak. Switzerland: Springer; 2019. p. 85–94.CrossRef

Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Glob Health. 2020;16(1):57. https://doi.org/10.1186/s12992-020-00589-w.CrossRef

Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–20.CrossRefPubMedPubMedCentral

Huarcaya-Victoria J, Villarreal-Zegarra D, Podestà A, Luna-Cuadros MA. Psychometric properties of a Spanish version of the fear of COVID-19 scale in general population of Lima, Peru. Int J Ment Health Addict. 2020:1–14. https://doi.org/10.1007/s11469-020-00354-5.

Greenwood BN, Thompson RS, Opp MR, Fleshner M. Repeated exposure to conditioned fear stress increases anxiety and delays sleep recovery following exposure to an acute traumatic stressor. Front Psychiatry. 2014;5:146. https://doi.org/10.3389/fpsyt.2014.00146.CrossRefPubMedPubMedCentral

Lutz B, Marsicano G, Maldonado R, Hillard CJ. The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci. 2015;16(12):705–18. https://doi.org/10.1038/nrn4036.CrossRefPubMedPubMedCentral

Ding J, Han F, Wen L, Xiao B, Shi Y. The role of β-arrestin-2 on fear/anxious-related memory in a rat model of post-traumatic stress disorder. J Affect Disord. 2017;213:1–8. https://doi.org/10.1016/j.jad.2016.12.043.CrossRefPubMed

Forbes D, Parslow R, Creamer M, O'Donnell M, Bryant R, McFarlane A, et al. A longitudinal analysis of posttraumatic stress disorder symptoms and their relationship with fear and anxious-misery disorders: implications for DSM-V. J Affect Disord. 2010;127(1–3):147–52. https://doi.org/10.1016/j.jad.2010.05.005.CrossRefPubMed

10.

Andrews G, Charney DS, Sirovatka PJ, Regier DA. Stress-induced and fear circuitry disorders: refining the research agenda for DSM-V. USA: American Psychiatric Pub; 2009.

11.

Siebenhaar KU, Köther AK, Alpers GW. Dealing with the COVID-19 Infodemic: distress by information, information avoidance, and compliance with preventive measures. Front Psychol. 2020;11:567905. https://doi.org/10.3389/fpsyg.2020.567905.CrossRefPubMedPubMedCentral

12.

Kim YJ. Posttraumatic stress disorder as a mediator between trauma exposure and comorbid mental health conditions in north Korean refugee youth resettled in South Korea. J Interpers Viol. 2016;31(3):425–43. https://doi.org/10.1177/0886260514555864.CrossRef

13.

An Y, Huang J, Chen Y, Deng Z. Longitudinal cross-lagged relationships between posttraumatic stress disorder and depression in adolescents following the Yancheng tornado in China. Psychol Trauma. 2019;11(7):760–6. https://doi.org/10.1037/tra0000455.CrossRefPubMed

14.

Ni MY, Jiang C, Cheng KK, Zhang W, Gilman SE, Lam TH, et al. Stress across the life course and depression in a rapidly developing population: the Guangzhou biobank cohort study. Int J Geriatr Psychiatry. 2016;31(6):629–37. https://doi.org/10.1002/gps.4370.CrossRefPubMed

15.

Sharafkhaneh A, Yohannes AM, Hanania NA, Kunik ME. Depression and anxiety in patients with chronic respiratory diseases. New York: Springer; 2017. https://doi.org/10.1007/978-1-4939-7009-4.CrossRef

16.

Rehman U, Shahnawaz MG, Khan NH, Kharshiing KD, Khursheed M, Gupta K, et al. Depression, anxiety and stress among Indians in times of Covid-19 lockdown. Community Ment Health J. 2020;57(1):1–7. https://doi.org/10.1007/s10597-020-00664-x.CrossRef

17.

Hair JF, Anderson RE, Tatham RL, Black WC. Análisis multivariante, vol. 491. España: Prentice Hall Madrid; 1999.

18.

Malaeb D, Salameh P, Barbar S, Awad E, Haddad C, Hallit R, et al. Problematic social media use and mental health (depression, anxiety, and insomnia) among Lebanese adults: any mediating effect of stress? Perspectives in psychiatric care; 2020.

19.

Park J, Elbert T, Kim SJ, Park J. The contribution of posttraumatic stress disorder and depression to insomnia in north Korean refugee youth. Front Psychiatry. 2019;10:211. https://doi.org/10.3389/fpsyt.2019.00211.CrossRefPubMedPubMedCentral

20.

Subica AM, Claypoole KH, Wylie AM. PTSD'S mediation of the relationships between trauma, depression, substance abuse, mental health, and physical health in individuals with severe mental illness: evaluating a comprehensive model. Schizophr Res. 2012;136(1–3):104–9. https://doi.org/10.1016/j.schres.2011.10.018.CrossRefPubMed

21.

Iacobucci D. Structural equations modeling: fit indices, sample size, and advanced topics. J Consum Psychol. 2010;20(1):90–8. https://doi.org/10.1016/j.jcps.2009.09.003.CrossRef

22.

Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict. 2020:1–9. https://doi.org/10.1007/s11469-020-00270-8.

23.

Weiss DS, et al. The impact of event scale—Revised. In: Wilson JP, Keane TM, editors. Assessing psychological trauma and PTSD: a practitioner’s handbook. New York: Guilford Press; 1997. p. 399–411.

24.

Guest R, Tran Y, Gopinath B, Cameron ID, Craig A. Prevalence and psychometric screening for the detection of major depressive disorder and post-traumatic stress disorder in adults injured in a motor vehicle crash who are engaged in compensation. BMC Psychol. 2018;6(1):4. https://doi.org/10.1186/s40359-018-0216-5.CrossRefPubMedPubMedCentral

25.

Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282(18):1737–44. https://doi.org/10.1001/jama.282.18.1737.CrossRefPubMed

26.

Manea L, Gilbody S, McMillan D. A diagnostic meta-analysis of the patient health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiatry. 2015;37(1):67–75. https://doi.org/10.1016/j.genhosppsych.2014.09.009.CrossRefPubMed

27.

Villarreal-Zegarra D, Copez-Lonzoy A, Bernabe-Ortiz A, Melendez-Torres GJ, Bazo-Alvarez JC. Valid group comparisons can be made with the patient health questionnaire (PHQ-9): a measurement invariance study across groups by demographic characteristics. PLoS One. 2019;14(9):e0221717. https://doi.org/10.1371/journal.pone.0221717.CrossRefPubMedPubMedCentral

28.

Spitzer RL, Kroenke K, Williams JW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7. https://doi.org/10.1001/archinte.166.10.1092.CrossRefPubMed

29.

Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24–31. https://doi.org/10.1016/j.genhosppsych.2015.11.005.CrossRefPubMed

30.

García-Campayo J, Zamorano E, Ruiz MA, Pardo A, Pérez-Páramo M, López-Gómez V, et al. Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes. 2010;8(1):8. https://doi.org/10.1186/1477-7525-8-8.CrossRefPubMedPubMedCentral

31.

Palomino-Oré C, Huarcaya-Victoria J. Trastornos por estrés debido a la cuarentena durante la pandemia por la COVID-19. J Horizonte Médico. 2020;20:e1218. https://doi.org/10.24265/horizmed.2020.v20n4.10.

32.

Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020;17(5). https://doi.org/10.3390/ijerph17051729.

33.

Kelley K, Pornprasertmanit S. Confidence intervals for population reliability coefficients: evaluation of methods, recommendations, and software for composite measures. Psychol Methods. 2016;21(1):69–92. https://doi.org/10.1037/a0040086.CrossRefPubMed

34.

Brown TA. Confirmatory factor analysis for applied research. 2nd ed. New York: The Guilford Press; 2015.

35.

Dominguez-Lara SA. ¿ Matrices policóricas/tetracóricas o matrices Pearson? Un estudio metodológico. Revista Argentina de Ciencias del Comportamiento. 2014;6(1):39–48.

36.

Timmerman ME, Lorenzo-Seva U. Dimensionality assessment of ordered polytomous items with parallel analysis. Psychol Methods. 2011;16(2):209–20. https://doi.org/10.1037/a0023353.CrossRefPubMed

37.

González-Rivera J, Rosario-Rodríguez A, Cruz-Santos A. Escala de Ansiedad por Coronavirus: Un Nuevo Instrumento para Medir Síntomas de Ansiedad Asociados al COVID-19. Interacciones. 2020;6(3):e163.CrossRef

38.

Hu L-T, Bentler PM. Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification. Psychol Methods. 1998;3(4):424–53. https://doi.org/10.1037/1082-989X.3.4.424.CrossRef

39.

Ferguson CJ. An effect size primer: a guide for clinicians and researchers. Prof Psychol Res Pract. 2009;40(5):532–8.CrossRef

40.

Pedraz-Petrozzi B, Krüger-Malpartida H, Arevalo-Flores M, Salmavides-Cuba F, Anculle-Arauco V, Dancuart-Mendoza M. Emotional impact on health personnel, medical students, and general population samples during the COVID-19 pandemic in Lima, Peru. Rev Colomb Psiquiatr. 2021;50(3):189–98. https://doi.org/10.1016/j.rcp.2021.04.006.

41.

Luo M, Guo L, Yu M, Jiang W, Wang H. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public - a systematic review and meta-analysis. Psychiatry Res. 2020;291:113190. https://doi.org/10.1016/j.psychres.2020.113190.CrossRefPubMedPubMedCentral

42.

Pappa S, Ntella V, Giannakas T, Giannakoulis VG, Papoutsi E, Katsaounou P. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis. Brain Behav Immun. 2020;88:901–7. https://doi.org/10.1016/j.bbi.2020.05.026.CrossRefPubMedPubMedCentral

43.

Hernández-Vásquez A, Vargas-Fernández R, Bendezu-Quispe G, Grendas LN. Depression in the Peruvian population and its associated factors: analysis of a national health survey. J Affect Disord. 2020;273:291–7. https://doi.org/10.1016/j.jad.2020.03.100.CrossRefPubMed

44.

Villarreal-Zegarra D, Cabrera-Alva M, Carrillo-Larco RM, Bernabe-Ortiz A. Trends in the prevalence and treatment of depressive symptoms in Peru: a population-based study. BMJ Open. 2020;10(7):e036777. https://doi.org/10.1136/bmjopen-2020-036777.CrossRefPubMedPubMedCentral

45.

Villarreal-Zegarra D, Bernabe-Ortiz A. Association between arterial hypertension and depressive symptoms: results from population-based surveys in Peru. Asia Pac Psychiatry. 2020;12(2):e12385. https://doi.org/10.1111/appy.12385.CrossRefPubMed

46.

Rodríguez-Hidalgo AJ, Pantaleón Y, Dios I, Falla D. Fear of COVID-19, Stress, and Anxiety in University Undergraduate Students: A Predictive Model for Depression. Front Psychol. 2020;11:591797. https://doi.org/10.3389/fpsyg.2020.591797.CrossRefPubMedPubMedCentral

47.

Lee J, Lee EH, Moon SH. Systematic review of the measurement properties of the depression anxiety stress Scales-21 by applying updated COSMIN methodology. Qual Life Res. 2019;28(9):2325–39. https://doi.org/10.1007/s11136-019-02177-x.CrossRefPubMed

48.

Blanco-Donoso LM, Moreno-Jiménez J, Amutio A, Gallego-Alberto L, Moreno-Jiménez B, Garrosa E. Stressors, job resources, fear of contagion, and secondary traumatic stress among nursing home Workers in Face of the COVID-19: the case of Spain. J Appl Gerontol. 2020;(3):244–56. https://doi.org/10.1177/0733464820964153.

49.

Tayyib NA, Alsolami FJ. Measuring the extent of stress and fear among registered nurses in KSA during the COVID-19 outbreak. J Taibah Univ Med Sci. 2020;15(5):410–6. https://doi.org/10.1016/j.jtumed.2020.07.012.CrossRefPubMedPubMedCentral

50.

Salehi L, Rahimzadeh M, Molaei E, Zaheri H, Esmaelzadeh-Saeieh S. The relationship among fear and anxiety of COVID-19, pregnancy experience, and mental health disorder in pregnant women: a structural equation model. Brain Behav. 2020;10(11):e01835. https://doi.org/10.1002/brb3.1835.CrossRefPubMedPubMedCentral

51.

Mahmud MS, Talukder MU, Rahman SM. Does ‘Fear of COVID-19’ trigger future career anxiety? An empirical investigation considering depression from COVID-19 as a mediator. Int J Soc Psychiatry. 2020;(1):35–45. https://doi.org/10.1177/0020764020935488.

52.

Boluarte-Carbajal A, Navarro-Flores A, Villarreal-Zegarra D. Explanatory model of perceived stress in the general population: a cross-sectional study in Peru during the COVID-19 context. Front Psychol. 2021;12:673945. https://doi.org/10.3389/fpsyg.2021.673945.CrossRefPubMedPubMedCentral

53.

Bakioğlu F, Korkmaz O, Ercan H. Fear of COVID-19 and positivity: mediating role of intolerance of uncertainty, depression, anxiety, and stress. Int J Ment Health Addict. 2020:1–14. https://doi.org/10.1007/s11469-020-00331-y.

54.

Voitsidis P, Nikopoulou VA, Holeva V, Parlapani E, Sereslis K, Tsipropoulou V, et al. The mediating role of fear of COVID-19 in the relationship between intolerance of uncertainty and depression. Psychol Psychother. 2020;94(3):884-93. https://doi.org/10.1111/papt.12315.

55.

Solomou I, Constantinidou F. Prevalence and Predictors of Anxiety and Depression Symptoms during the COVID-19 Pandemic and Compliance with Precautionary Measures: Age and Sex Matter. Int J Environ Res Public Health. 2020;17(14). https://doi.org/10.3390/ijerph17144924.

56.

Nwachukwu I, Nkire N, Shalaby R, Hrabok M, Vuong W, Gusnowski A, et al. COVID-19 Pandemic: Age-Related Differences in Measures of Stress, Anxiety and Depression in Canada. Int J Environ Res Public Health. 2020;17(17). https://doi.org/10.3390/ijerph17176366.

57.

Muhammad Alfareed Zafar S, Junaid Tahir M, Malik M, Irfan Malik M, Kamal Akhtar F, Ghazala R. Awareness, anxiety, and depression in healthcare professionals, medical students, and general population of Pakistan during COVID-19 Pandemic: A cross sectional online survey. Med J Islam Repub Iran. 2020;34:131. https://doi.org/10.47176/mjiri.34.131.CrossRefPubMedPubMedCentral

58.

Waring S, Giles S. Rapid evidence assessment of mental health outcomes of pandemics for health care workers: implications for the Covid-19 pandemic. Front Public Health. 2021;9:629236. https://doi.org/10.3389/fpubh.2021.629236.CrossRefPubMedPubMedCentral

59.

Ministerio de Salud. Plan Nacional de Fortalecimiento de Servicios de Salud Mental Comunitaria 2018–2021. Perú: Ministerio de Salud; 2018.

60.

Patel V, Saxena S, Lund C, Thornicroft G, Baingana F, Bolton P, et al. The Lancet Commission on global mental health and sustainable development. Lancet. 2018;392(10157):1553–98.

61.

Cavero V, Hidalgo L, Rivera D. Perfil de País: Perú - Análisis para una campaña y defensa de la salud mental. UK: Mental Health Innovation Network; 2020.

Title: Depression, post-traumatic stress, anxiety, and fear of COVID-19 in the general population and health-care workers: prevalence, relationship, and explicative model in Peru
Authors: David Villarreal-Zegarra
Anthony Copez-Lonzoy
Ana L. Vilela-Estrada
Jeff Huarcaya-Victoria
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Mood Disorders
Care
Affective Disorder
COVID-19
Anxiety
Published in: BMC Psychiatry / Issue 1/2021
Electronic ISSN: 1471-244X
DOI: https://doi.org/10.1186/s12888-021-03456-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Depression, post-traumatic stress, anxiety, and fear of COVID-19 in the general population and health-care workers: prevalence, relationship, and explicative model in Peru

Abstract

Background

Method

Results

Limitations

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Method

Results

Limitations

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Comorbidity of depression and anxiety leads to a poor prognosis following angina pectoris patients: a prospective study

Prevalence and associated factors of psychosocial distress among seafarers during COVID-19 pandemic

A novel model to predict mental distress among medical graduate students in China

Self-evaluation as an active ingredient in the experience and treatment of adolescent depression; an integrated scoping review with expert advisory input

Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial

Evaluating the validity and reliability of the Chinese entrapment scale and the relationship to depression among men who have sex with men in Shanghai, China